# Citius Oncology, Inc.: Form 8-K, filed Aug 5, 2026

- Company: [Citius Oncology, Inc.](/companies/ctor.md) (CIK 1851484)
- Form: 8-K
- Filed: 2026-08-05
- Accepted by EDGAR: Aug 5, 2026, 09:28 ET
- Period: 2026-08-05
- Accession: 0001213900-26-085434
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1851484/000121390026085434/ea0300371-8k_citius.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1851484/000121390026085434/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1851484/000121390026085434/ea0300371-8k_citius.htm

Filed Aug 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-085434. Last ingested by Listed: Nov 4, 2026, 17:46 ET. No prices; not investment advice.